Abstract | OBJECTIVE: METHODS: Vascular reactivity experiments were performed in aortic segments from normotensive, Wistar-Kyoto, and spontaneously hypertensive rats (SHR); protein expression was measured by western blot and/or immunohistochemistry, and prostaglandin F2alpha ( PGF2alpha), 8-isoprostane and prostacyclin release were determined by enzyme immunoassay commercial kits. RESULTS: The protein synthesis inhibitor dexamethasone (1 micromol/l), the non-selective cyclooxygenase inhibitor indomethacin (10 micromol/l), the selective cyclooxygenase-2 inhibitor NS 398 (1 micromol/l), and the thromboxane A2/ prostaglandin H2 ( TP) receptor antagonist SQ 29,548 (1 micromol/l), reduced the concentration-response curves to phenylephrine more in segments from hypertensive than from normotensive rats; however, the thromboxane A2 (TxA2) synthase inhibitors furegrelate (10 micromol/l) and OKY 046 (1 and 10 micromol/l) had no effect in either strain. Removing endothelium or adding dexamethasone almost abolished the NS 398 effect. Cyclooxygenase-2 protein expression, which was reduced by dexamethasone, was higher in aorta from hypertensive animals. In both strains cyclooxygenase-2 was localized mainly in endothelial cells and adventitial fibroblasts. 13,14-Dihydro-15-keto-PGF2alpha, 6-keto-PGF1alpha and 8-isoprostane levels were greater in the medium from hypertensive than from normotensive rats; NS 398 decreased levels of the three metabolites studied only in the medium from SHR. CONCLUSIONS:
|
Authors | Yolanda Alvarez, Ana M Briones, Gloria Balfagón, María J Alonso, Mercedes Salaices |
Journal | Journal of hypertension
(J Hypertens)
Vol. 23
Issue 4
Pg. 767-77
(Apr 2005)
ISSN: 0263-6352 [Print] England |
PMID | 15775781
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
- Nitrobenzenes
- Prostaglandins
- Sulfonamides
- Vasoconstrictor Agents
- N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
- Phenylephrine
- 15-keto-13,14-dihydroprostaglandin F2alpha
- 8-epi-prostaglandin F2alpha
- Dinoprost
- Cyclooxygenase 2
- Prostaglandin-Endoperoxide Synthases
|
Topics |
- Animals
- Aorta
(physiology)
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
(pharmacology)
- Dinoprost
(analogs & derivatives, metabolism)
- Endothelium, Vascular
(enzymology)
- Hypertension
(metabolism)
- Male
- Nitrobenzenes
(pharmacology)
- Phenylephrine
(pharmacology)
- Prostaglandin-Endoperoxide Synthases
(metabolism)
- Prostaglandins
(metabolism)
- Rats
- Rats, Inbred SHR
- Rats, Inbred WKY
- Sulfonamides
(pharmacology)
- Vasoconstriction
(drug effects, physiology)
- Vasoconstrictor Agents
(pharmacology)
|